These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 9433643)
21. Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition). Gray J; Mao JT; Szabo E; Kelley M; Kurie J; Bepler G; Chest; 2007 Sep; 132(3 Suppl):56S-68S. PubMed ID: 17873160 [TBL] [Abstract][Full Text] [Related]
22. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia. Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933 [TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of lung cancer: the rise and demise of beta-carotene. Omenn GS Annu Rev Public Health; 1998; 19():73-99. PubMed ID: 9611613 [TBL] [Abstract][Full Text] [Related]
24. Secondary chemoprevention of upper aerodigestive tract tumors. Anderson WF; Hawk E; Berg CD Semin Oncol; 2001 Feb; 28(1):106-20. PubMed ID: 11254870 [TBL] [Abstract][Full Text] [Related]
25. Carcinogen biomarkers for lung or oral cancer chemoprevention trials. Hecht SS IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664 [TBL] [Abstract][Full Text] [Related]
26. Prevention of lung cancer. Goodman GE Curr Opin Oncol; 1998 Mar; 10(2):122-6. PubMed ID: 9555534 [TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of lung cancer. van Zandwijk N Lung Cancer; 2001 Dec; 34 Suppl 3():S91-4. PubMed ID: 11741000 [TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of lung cancer. Vignot S; Spano JP; Lantuejoul S; André F; Le Chevalier T; Soria JC Recent Results Cancer Res; 2005; 166():145-65. PubMed ID: 15648189 [TBL] [Abstract][Full Text] [Related]
29. Lung cancer: genetics of risk and advances in chemoprevention. Keith RL; Miller YE Curr Opin Pulm Med; 2005 Jul; 11(4):265-71. PubMed ID: 15928489 [TBL] [Abstract][Full Text] [Related]
33. Chemoprevention of oral squamous cell carcinomas. Scheer M; Kuebler AC; Zöller JE Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354 [TBL] [Abstract][Full Text] [Related]
34. Chemoprevention of second cancers. Mayne ST; Cartmel B Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2033-7. PubMed ID: 17057027 [TBL] [Abstract][Full Text] [Related]
35. Retinoids: application in premalignant lesions and oral cancer. Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628 [TBL] [Abstract][Full Text] [Related]
36. Risk biomarkers and current strategies for cancer chemoprevention. Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592 [TBL] [Abstract][Full Text] [Related]
37. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future. Omenn GS Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088 [TBL] [Abstract][Full Text] [Related]
38. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335 [TBL] [Abstract][Full Text] [Related]
39. Chemoprevention of lung cancer. Keith RL Proc Am Thorac Soc; 2009 Apr; 6(2):187-93. PubMed ID: 19349487 [TBL] [Abstract][Full Text] [Related]
40. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials. Greenwald P J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]